Cargando…

The Potential Clinical Utility of Circulating Tumor DNA in Esophageal Adenocarcinoma: From Early Detection to Therapy

Esophageal adenocarcinoma (EAC) is a lethal cancer requiring improved screening strategies and treatment options due to poor detection methods, aggressive progression, and therapeutic resistance. Emerging circulating tumor DNA (ctDNA) technologies may offer a unique non-invasive strategy to better c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kosovec, Juliann E., Zaidi, Ali H., Pounardjian, Tamar S., Jobe, Blair A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297385/ https://www.ncbi.nlm.nih.gov/pubmed/30619750 http://dx.doi.org/10.3389/fonc.2018.00610

Ejemplares similares

Prognostic immune markers for recurrence and survival in locally advanced esophageal adenocarcinoma
por: Babar, Laila, et al.
Publicado: (2019)

Intratumoral immunotherapy with STING agonist, ADU-S100, induces CD8+ T-cell mediated anti-tumor immunity in an esophageal adenocarcinoma model
por: Zaidi, Ali H., et al.
Publicado: (2021)

MicroRNA Signature Characterizes Primary Tumors That Metastasize in an Esophageal Adenocarcinoma Rat Model
por: Zaidi, Ali H., et al.
Publicado: (2015)

Establishing Magnetic Resonance Imaging as an Accurate and Reliable Tool to Diagnose and Monitor Esophageal Cancer in a Rat Model
por: Kosovec, Juliann E., et al.
Publicado: (2014)

Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma
por: Matsui, Daisuke, et al.
Publicado: (2016)

CDK4/6 dual inhibitor abemaciclib demonstrates compelling preclinical activity against esophageal adenocarcinoma: a novel therapeutic option for a deadly disease
por: Kosovec, Juliann E., et al.
Publicado: (2017)

Prognostic Value and Targeted Inhibition of Survivin Expression in Esophageal Adenocarcinoma and Cancer-Adjacent Squamous Epithelium
por: Malhotra, Usha, et al.
Publicado: (2013)

Clinical Utility of Circulating Tumor Cells in Patients With Esophageal Cancer
por: Li, Yang, et al.
Publicado: (2022)

Potential Clinical Utility of a Targeted Circulating Tumor DNA Assay in Esophageal Adenocarcinoma
por: Cabalag, Carlos S., et al.
Publicado: (2022)

High yield reproducible rat model recapitulating human Barrett’s carcinogenesis
por: Matsui, Daisuke, et al.
Publicado: (2017)

Clinical Utility of Circulating Tumor DNA in Advanced Rare Cancers
por: Okuma, Hitomi Sumiyoshi, et al.
Publicado: (2021)

Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma
por: Guan, Shasha, et al.
Publicado: (2022)

Blood Circulating miRNA Pairs as a Robust Signature for Early Detection of Esophageal Cancer
por: Song, Yang, et al.
Publicado: (2021)

Detection and utility of cell-free and circulating tumour DNA in bone and soft-tissue sarcomas
por: Tsoi, Kim M., et al.
Publicado: (2021)

An Improved Detection of Circulating Tumor DNA in Extracellular Vesicles-Depleted Plasma
por: Sun, Li, et al.
Publicado: (2021)

Plasma Circulating Tumor DNA Sequencing Predicts Minimal Residual Disease in Resectable Esophageal Squamous Cell Carcinoma
por: Liu, Tao, et al.
Publicado: (2021)

Circulating Cell-Free Tumor DNA in Advanced Pancreatic Adenocarcinoma Identifies Patients With Worse Overall Survival
por: Botrus, Gehan, et al.
Publicado: (2022)

Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection
por: Fiala, Clare, et al.
Publicado: (2018)

Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma
por: Matani, Hirsch, et al.
Publicado: (2022)

A clinical prognostic model for patients with esophageal squamous cell carcinoma based on circulating tumor DNA mutation features
por: Liu, Tao, et al.
Publicado: (2023)

Adjunctive Use of Circulating Tumor DNA Testing in Detecting Pancreas Cancer Recurrence
por: Soyano, Aixa E., et al.
Publicado: (2019)

The Utility of Symptom Association Probability (SAP) in Predicting Outcome After Laparoscopic Fundoplication in Patients with Abnormal Esophageal Acid Exposure
por: Vaiciunaite, Donata, et al.
Publicado: (2023)

Detection of Circulating Tumor Cells in Resectable Pancreatic Ductal Adenocarcinoma: A Prospective Evaluation as a Prognostic Marker
por: Song, Byeong Geun, et al.
Publicado: (2021)

A New Horizon of Liquid Biopsy in Thymic Epithelial Tumors: The Potential Utility of Circulating Cell-Free DNA
por: Ottaviano, Margaret, et al.
Publicado: (2021)

Circulating Tumor DNA Detection in the Management of Anti-EGFR Therapy for Advanced Colorectal Cancer
por: Knebel, Franciele H., et al.
Publicado: (2019)

Genomic Variations in Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma
por: Yasar, Hatime A
Publicado: (2023)

Circulating tumor biomarkers in early-stage breast cancer: characteristics, detection, and clinical developments
por: Qiu, Jie, et al.
Publicado: (2023)

Prognostic Value of Postoperative Circulating Tumor DNA in Patients With Early- and Intermediate-Stage Hepatocellular Carcinoma
por: Ye, Ke, et al.
Publicado: (2022)

Serial Circulating Tumor DNA Detection Using a Personalized, Tumor-Informed Assay in Esophageal Adenocarcinoma Patients Following Resection
por: Ococks, Emma, et al.
Publicado: (2021)

Case report: Cerebrospinal fluid-derived circulating tumor DNA diagnoses and guides the treatment of a lung adenocarcinoma case with leptomeningeal metastasis
por: Bai, Yujun, et al.
Publicado: (2022)

Plasma-only circulating tumor DNA analysis detects minimal residual disease and predicts early relapse in hepatocellular carcinoma patients undergoing curative resection
por: Xu, Yuyan, et al.
Publicado: (2023)

The Challenges of Detecting Circulating Tumor Cells in Sarcoma
por: Tellez-Gabriel, Marta, et al.
Publicado: (2016)

The Clinical Landscape of Circulating Tumor DNA in Gastrointestinal Malignancies
por: Sawada, Kentaro, et al.
Publicado: (2018)

The Use of Circulating Tumor DNA for Prognosis of Gastrointestinal Cancers
por: Saluja, Hariti, et al.
Publicado: (2018)

A Review of Circulating Tumor DNA in Hepatobiliary Malignancies
por: Mody, Kabir, et al.
Publicado: (2018)

Application of Data Science in Circulating Tumor DNA Detection: A Promising Avenue Towards Liquid Biopsy
por: Li, Ming, et al.
Publicado: (2021)

Circulating tumor DNA detection in MRD assessment and diagnosis and treatment of non-small cell lung cancer
por: Fang, Xiaoxu, et al.
Publicado: (2022)

Visceral Obesity, Metabolic Syndrome, and Esophageal Adenocarcinoma
por: Elliott, Jessie A., et al.
Publicado: (2021)

Esophageal adenocarcinoma with metastasis to the prostatic urethra and bladder
por: Olawoyin, Olamide M., et al.
Publicado: (2023)

Circulating Tumor DNA as a Potential Marker to Detect Minimal Residual Disease and Predict Recurrence in Pancreatic Cancer
por: Jiang, Jiahong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_35in85eqm2ngsr42v0oo6jlhg6